Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 5 of 5 results for electrochemotherapy

  1. Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma (IPG478)

    Evidence-based recommendations on electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma. This involves injecting a chemotherapy drug into the tumour and using electrical pulses to increase its effect.

    Interventional procedures guidance
    Published
    26 February 2014
    View recommendations

    Sections for IPG478

  2. Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma (IPG446)

    Evidence-based recommendations on electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma. This involves applying short, powerful pulses of electricity to the tumour, allowing an anticancer drug to pass through into the cells.

    Interventional procedures guidance
    Published
    27 March 2013
    View recommendations

    Sections for IPG446

  3. Electrochemotherapy for the treatment of malignant melanoma

    Discontinued [GID-IP1041]

    Interventional procedures guidance
    Discontinued

  4. Melanoma: assessment and management (NG14)

    This guideline covers the assessment and management of melanoma (a type of skin cancer) in children, young people and adults. It aims to reduce variation in practice and improve survival.

    NICE guideline
    Last updated
    27 July 2022
    View recommendations

    Sections for NG14

  5. Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma (IPG447)

    This guidance has been updated and replaced by NICE interventional procedures guidance 478.

    Interventional procedures guidance
    Published
    27 March 2013